Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer

PURPOSE: Although adjuvant polychemotherapy improves outcomes for early breast cancer, the significant variability in terms of pharmacokinetics results in differences in efficacy and both short and long-term toxicities. Retrospective studies support the use of dose tailoring according to the hematol...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Breast Cancer Res Treat
Prif Awduron: Matikas, Alexios, Margolin, Sara, Hellström, Mats, Johansson, Hemming, Bengtsson, Nils-Olof, Karlsson, Lena, Edlund, Per, Karlsson, Per, Lidbrink, Elisabet, Linderholm, Barbro, Lindman, Henrik, Malmstrom, Per, Villman, Kenneth, Foukakis, Theodoros, Bergh, Jonas
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer US 2017
Pynciau:
Clinical Trial
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838137/
https://ncbi.nlm.nih.gov/pubmed/29190004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4599-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg